Clinical Trial Transparency & Disclosure

How to Design Patient Access to Results & Return of Data That Meets FDA, EMA and MHRA Expectations How to Design Patient Access to Results & Return of Data That Meets FDA, EMA and MHRA Expectations Clinical trials play a crucial role in advancing medical science and improving patient care. An essential regulatory requirement across…

Read More “How to Design Patient Access to Results & Return of Data That Meets FDA, EMA and MHRA Expectations” »

Patient Access to Results & Return of Data: Compliance Strategy for US, EU and UK Clinical Programs Patient Access to Results & Return of Data: Compliance Strategy for US, EU and UK Clinical Programs With the increasing emphasis on transparency in clinical trials, the need for patient access to results and the return of data…

Read More “Patient Access to Results & Return of Data: Compliance Strategy for US, EU and UK Clinical Programs” »

Common Pitfalls in Patient Access to Results & Return of Data—and How to Avoid Costly Findings Common Pitfalls in Patient Access to Results & Return of Data—and How to Avoid Costly Findings Access to results and data return is a critical yet often overlooked aspect of clinical trial management. This guide outlines common pitfalls and…

Read More “Common Pitfalls in Patient Access to Results & Return of Data—and How to Avoid Costly Findings” »

Patient Access to Results & Return of Data in Practice: Step-by-Step Guide for Sponsors and CROs Patient Access to Results & Return of Data in Practice: Step-by-Step Guide for Sponsors and CROs The subject of patient access to results after participation in clinical trials is a critical aspect of clinical research and regulatory compliance. With…

Read More “Patient Access to Results & Return of Data in Practice: Step-by-Step Guide for Sponsors and CROs” »

Patient Access to Results & Return of Data Playbook for High-Profile and Late-Phase Trials Patient Access to Results & Return of Data Playbook for High-Profile and Late-Phase Trials In the landscape of clinical research, ensuring transparency and accessibility to clinical trial results is imperative. This is especially significant for high-profile and late-phase clinical trials, where…

Read More “Patient Access to Results & Return of Data Playbook for High-Profile and Late-Phase Trials” »

Aligning Patient Access to Results & Return of Data With ICH, GCP and Transparency Regulations Aligning Patient Access to Results & Return of Data With ICH, GCP and Transparency Regulations In the landscape of clinical trials, particularly those related to schizophrenia, there is an increasing emphasis on patient engagement and the transparent return of data….

Read More “Aligning Patient Access to Results & Return of Data With ICH, GCP and Transparency Regulations” »

Inspection and Audit Readiness: Documenting Patient Access to Results & Return of Data for Regulators Inspection and Audit Readiness: Documenting Patient Access to Results & Return of Data for Regulators In the contemporary clinical research landscape, maintaining compliance with regulatory standards while ensuring patient engagement is crucial. The emphasis on transparency and disclosure has led…

Read More “Inspection and Audit Readiness: Documenting Patient Access to Results & Return of Data for Regulators” »